This is just a development update while things are in still progress. I suspect it may not have been issued if not because of the many emails from SH to Mark Diamond.
So the status quo is still exist for those who can accumulate for the anns that matter:
Pharma licensing, ATL1101 licensing/funding/investor, ATL1103 funding and commencement, ATL1102 licensing.
These are the anns that will see explosion of SP, warranted or not. IMO
- Forums
- ASX - By Stock
- PER
- atl1103 development update
atl1103 development update, page-32
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.79M |
Open | High | Low | Value | Volume |
8.1¢ | 8.2¢ | 7.9¢ | $135.8K | 1.691M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 112037 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 394602 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 112037 | 0.080 |
12 | 936749 | 0.079 |
7 | 479515 | 0.078 |
5 | 777652 | 0.077 |
4 | 296000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 394602 | 6 |
0.082 | 183268 | 1 |
0.083 | 55904 | 2 |
0.084 | 18405 | 1 |
0.086 | 96543 | 1 |
Last trade - 13.27pm 15/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online